Biodesix Inc — Bilan (NASDAQ:BDSX) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 121.07 M76.1 M92.91 M99.1 M97.24 M87.48 M Total du passif 79.9 M56.37 M72.3 M94.52 M76.37 M89.94 M Total des capitaux propres 41.17 M19.73 M20.61 M4.58 M20.88 M-2.46 M Total du passif et des capitaux propres 121.07 M76.1 M92.91 M99.1 M97.24 M87.48 M Dette totale 27.77 M10.01 M25.05 M35.28 M36.43 M47.45 M Dette nette -34.36 M-22.7 M-18.04 M8.99 M10.18 M28.46 M

Nouvelles

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Canaccord relève l’objectif de cours de Biodesix à 22$ sur fond de croissance du chiffre d’affaires

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Here's Why You Should Add DexCom Stock to Your Portfolio Now

MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%